AEZS Aeterna Zentaris Inc

QUEBEC CITY, Feb. 23 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (NASDAQ:AEZSNASDAQ:TSX:NASDAQ:AEZ), (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Cancer: Improving Treatment through Combination Therapy" at the RBC Capital Markets Healthcare Conference on Wednesday, March 3, 2010, from 8:00 am to 8:55 am (eastern) in the Holmes I Room of The New York Palace Hotel in New York City. A live audio webcast of the panel discussion will be available in the Investors section of the Company's website at http://www.aezsinc.com/. A replay of the webcast will also be available on its website for a period of 30 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at http://www.aezsinc.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418) 652-8525 ext. 265, ; Media Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406,

Copyright